Tricuspid valve surgery: Recent experience at the Chaim Sheba Medical Center

From 1 January 1989 to 30 June 1992, 35 patients underwent cardiac surgery that included a tricuspid valve (TV) procedure. All had severe TV dysfunction documented by echocardiography, and were in NYHA functional class III-IV. The etiology of TV dysfunction was rheumatic-functional in 19 patients, rheumatic-organic in 13, and infective in 3. Nineteen (54%) had had at least one previous cardiac operation, and in 29 an associated procedure (MVR, AVR, DVR, DVR + CABG) had been performed. The TV was repaired in 27 patients, was replaced by a bioprosthesis in 7, and was excised in 1. There were three (8.6%) operative and two late deaths. Except for two, all surviving patients are in NYHA functional class I-II. In two patients with organic lesions who underwent repair, residual moderate tricuspid regurgitation was observed. We conclude that in these critically ill patients TV surgery can be performed with acceptable results. Long-term fate of a bioprosthesis in the tricuspid position is yet to be determined.